Design Therapeutics' Friedreich's ataxia data; Vincentage's obesity results from China

May 18, 2026 10:56 AM EDT News Briefing De­sign Ther­a­peu­tic­s' Friedre­ich atax­ia da­ta; Vin­cen­t­age's obe­si­ty re­sults from Chi­na ENDPOINTS Plus, news about En­her­tu and Tecen­triq. 💪 De­sign Ther­a­peu­tics shares Phase 1/2 da­ta in Friedre­ich atax­ia: The Cal­i­for­nia biotech’s DT-216P2 giv­en at 1 mg/kg Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER